Details of the Drug Formulations

General Information of Drug (ID: DM8JRH0)

• Drug Name: Cangrelor Drug Info
• Synonyms: Cangrelor; 163706-06-7; Kengreal; UNII-6AQ1Y404U7; AR-C69931XX; CHEMBL334966; 6AQ1Y404U7; kengrexal; 5'-O-[({[dichloro(phosphono)methyl](hydroxy)phosphoryl}oxy)(hydroxy)phosphoryl]-N-[2-(methylsulfanyl)ethyl]-2-[(3,3,3-trifluoropropyl)sulfanyl]adenosine; 5'-Adenylicacid,N-[2-(methylthio)ethyl]-2-[(3,3,3-trifluoropropyl)thio]-,anhydridewithP,P'-(dichloromethylene)bis[phosphonicacid](1:1)

Indication

Disease Entry	ICD 11	Status	REF
Thrombosis	DB61-GB90	Approved	[1]

• Cross-matching ID:
  PubChem CID: 9854012
  ChEBI ID: CHEBI:90841
  CAS Number: 163706-06-7
  TTD ID: D09QBG
  ACDINA ID: D00908

Full List of Drug Formulations Containing This Drug

Cangrelor 50mg/vial powder

Company	Formulation ID	FDA Description
Chiesi	F23098	Mannitol; Sorbitol; Sodium Hydroxide

References

• [1] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1776).